221 related articles for article (PubMed ID: 14740176)
1. Dendritic cells are dysfunctional in patients with operable breast cancer.
Satthaporn S; Robins A; Vassanasiri W; El-Sheemy M; Jibril JA; Clark D; Valerio D; Eremin O
Cancer Immunol Immunother; 2004 Jun; 53(6):510-8. PubMed ID: 14740176
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.
Satthaporn S; Aloysius MM; Robins RA; Verma C; Chuthapisith S; McKechnie AJ; El-Sheemy M; Vassanasiri W; Valerio D; Clark D; Jibril JA; Eremin O
BMC Immunol; 2008 Jun; 9():32. PubMed ID: 18588665
[TBL] [Abstract][Full Text] [Related]
3. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
4. Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction.
Cao MD; Chen ZD; Xing Y
Cell Biol Int; 2004; 28(3):223-8. PubMed ID: 14984749
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.
Ratta M; Fagnoni F; Curti A; Vescovini R; Sansoni P; Oliviero B; Fogli M; Ferri E; Della Cuna GR; Tura S; Baccarani M; Lemoli RM
Blood; 2002 Jul; 100(1):230-7. PubMed ID: 12070032
[TBL] [Abstract][Full Text] [Related]
7. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation.
Pinzon-Charry A; Maxwell T; Prato S; Furnival C; Schmidt C; López JA
Neoplasia; 2005 Dec; 7(12):1123-32. PubMed ID: 16354595
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.
Futalan D; Huang CT; Schmidt-Wolf IG; Larsson M; Messmer D
Mol Med; 2011; 17(9-10):910-6. PubMed ID: 21647537
[TBL] [Abstract][Full Text] [Related]
11. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptor.
Carucci JA; Ignatius R; Wei Y; Cypess AM; Schaer DA; Pope M; Steinman RM; Mojsov S
J Immunol; 2000 Apr; 164(7):3494-9. PubMed ID: 10725702
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences.
Raje N; Gong J; Chauhan D; Teoh G; Avigan D; Wu Z; Chen D; Treon SP; Webb IJ; Kufe DW; Anderson KC
Blood; 1999 Mar; 93(5):1487-95. PubMed ID: 10029575
[TBL] [Abstract][Full Text] [Related]
15. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
16. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.
Huang YM; Stoyanova N; Jin YP; Teleshova N; Hussien Y; Xiao BG; Fredrikson S; Link H
Clin Exp Immunol; 2001 May; 124(2):306-14. PubMed ID: 11422209
[TBL] [Abstract][Full Text] [Related]
17. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells.
Scheinecker C; Machold KP; Majdic O; Höcker P; Knapp W; Smolen JS
J Immunol; 1998 Oct; 161(8):3966-73. PubMed ID: 9780165
[TBL] [Abstract][Full Text] [Related]
18. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
[TBL] [Abstract][Full Text] [Related]
19. Decreased antigen presentation by dendritic cells in patients with breast cancer.
Gabrilovich DI; Corak J; Ciernik IF; Kavanaugh D; Carbone DP
Clin Cancer Res; 1997 Mar; 3(3):483-90. PubMed ID: 9815709
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids hamper the ex vivo maturation of lung dendritic cells from their low autofluorescent precursors in the human bronchoalveolar lavage: decreases in allostimulatory capacity and expression of CD80 and CD86.
Verhoeven GT; Van Haarst JM; De Wit HJ; Simons PJ; Hoogsteden HC; Drexhage HA
Clin Exp Immunol; 2000 Nov; 122(2):232-40. PubMed ID: 11091280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
